volume 20, issue 3, P187-192 1994
DOI: 10.1007/bf01704698
View full text
|
Sign up to set email alerts
|
Share

Abstract: This study suggests that the administration of intratracheal colistin during a 2-week period significantly reduces the incidence of Gram-negative BPN without creating an increasing number of BPN due to colistin-resistant micro-organisms.